Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement.
作者信息
Grogan M, Gertz M A, Kyle R A, Tajik A J
机构信息
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota 55901, USA.
出版信息
Am J Cardiol. 2000 Mar 1;85(5):664-5, A11. doi: 10.1016/s0002-9149(99)00832-2.
Abstract
Survival of > or =5 years was seen in 8 of 153 patients (5%) with primary systemic amyloidosis and cardiac involvement. All patients with survival of >5 years received chemotherapy and all but 1 had an objective chemotherapeutic response.
摘要
Zotero 插件